HOME >> BIOLOGY >> NEWS
Genetic mutation linked to more aggressive breast cancer found more often in African-Americans

Alterations in a tumor suppressor gene called p53 are more prevalent in breast cancer of African-American women than white women, according to a new study. This study, published August 9, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, "represents the first reported series of increased prevalence of p53 alterations in African-American breast cancer patients," according to an accompanying editorial. Free abstracts of the study and editorial will be available via Wiley InterScience (http://www.interscience.wiley.com/cancer-newsroom) upon embargo.

Ethnic differences in the incidence and mortality rates of breast cancer are noted in the United States and worldwide. In the U.S., the most apparent differences are seen between African-American and white women. African-American women have lower incidence rates of the disease, but have higher mortality rates. Moreover, African-American women present at a younger age and with more aggressive disease.

Explanations for these racial/ethnic differences have included socioeconomic factors, nutrition, medical comorbidities, and healthcare behavior. However, analyses demonstrate that higher mortality risk remains independent of these factors. Recent studies also show that tumors in African-Americans have significant different molecular characteristics on histopathology, such as lacking estrogen receptors.

Beth A. Jones, Ph.D., M.P.H., from Yale University School of Medicine and her colleagues studied the breast tumors of 145 African-American and 177 white women to further characterize the pattern of alterations of genes known to relate to tumor development and be associated with worse prognosis.

The authors found that African-American women were four times more likely than white women to show significant alterations in a tumor suppressor gene, p53. However, the prevalence of alterations in oth
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
9-Aug-2004


Page: 1 2

Related biology news :

1. Genetic mutations linked to the practice of burning coal in homes in China
2. Genetic differences might help distinguish thyroid cancers
3. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
4. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
5. Genetically modified bacterium as remedy for intestinal diseases
6. Genetic analysis rewrites salamanders evolutionary history
7. Genetic map of important tree genes outlined
8. Genetically-engineered marathon mouse keeps on running
9. Genetic clues found for common congenital brain disorder
10. Genetic discovery could dramatically reduce need for liver transplants in children
11. Genetic model for devastating form of paraplegia suggests new treatments

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/30/2019)... YORK (PRWEB) , ... January ... ... nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science and ... professionals representing 10 national nonprofit disease foundations and disease-focused venture funds to ...
(Date:1/25/2019)... ... January 24, 2019 , ... Review methodology could negatively ... states continue to grapple with prescription drug costs, a new Pioneer Institute ... should address before deciding whether to contract with the Institute for Clinical and ...
(Date:1/20/2019)... ... ... As the leader in 3D cell culture characterization and analysis, Visikol is now ... models. In an effort to build a consensus in the market, Visikol will be ... replicate these models for their internal research efforts. , Recently, researchers have begun ...
Breaking Biology News(10 mins):
(Date:2/12/2019)... ... February 12, 2019 , ... ... has finalized a deal to extend their use of Medrio, the leading provider ... 2023. The CRO has been a regular Medrio customer for over nine years, ...
(Date:2/2/2019)... ... February 01, 2019 , ... Biomatlante, a world leader in ... CEO, Julien Dert, being effective on February 1st, 2019. , Graduated from ICN ... in which more than 12 years in the Medical Device industry. Chief Financial ...
(Date:1/30/2019)... , ... January 29, 2019 , ... K&R Negotiations announced ... expert at a special online event titled: Six Ways to Shorten the Sales ... time, February 13, 2019 on the BrightTALK network. , Negotiation expert Kresic will ...
(Date:1/28/2019)... ... January 28, 2019 , ... Fragment-based lead discovery (FBLD) involves ... early stage, false positives can be problematic due to high levels of solvents ... techniques are highly sensitive to detect weak interactions. Nanomed , leading producer ...
Breaking Biology Technology:
Cached News: